Alexander Ijsselmuiden

机构：Maastricht University Medical Centre, Maastricht University, Amphia Ziekenhuis, Zuyderland Medisch Centrum

发表论文 140 篇 · 总被引 3001 次 · h-index 23

代表论文

• Continuation versus Interruption of Oral Anticoagulation during TAVI (2024 · New England Journal of Medicine · 被引 31)
• FFR-Negative Nonculprit High-Risk Plaques and Clinical Outcomes in High-Risk Populations: An Individual Patient-Data Pooled Analysis From COMBINE (OCT-FFR) and PECTUS-obs (2025 · Circulation Cardiovascular Interventions · 被引 23)
• Early outcomes of the novel Myval THV series compared to SAPIEN THV series and Evolut THV series in individuals with severe aortic stenosis (2025 · EuroIntervention · 被引 15)
• Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial (2025 · EuroIntervention · 被引 10)
• Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk (2024 · JACC: Cardiovascular Interventions · 被引 9)
• Win ratio analysis of the LANDMARK trial (2025 · American Heart Journal · 被引 4)